Anti-SOST/Sclerostin Antibody (Blosozumab)
Catalog No.
F1739
Anti-SOST/Sclerostin Antibody (Blosozumab)
Featured Products
Blosozumab (LY2541546) is an antibody inhibitor of human sclerostin (SOST). Blosozumab stimulates bone formation and reduces bone resorption. Blosozumab can be used in osteoporosis research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1132758-87-2
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
TST-002, LY-2541546
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9BQB4
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
SOST / Sclerostin
Please avoid freeze-thaw cycles.